Last reviewed · How we verify
NCT06604221: REHDP
Resistance Exercise in Hemodialysis Patients
NA trial testing Resistance exercise intervention in Hemodialysis in 54 participants. Not yet recruiting.
3 January 2025
Quick facts
| Lead sponsor | Teng Zeng |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 54 |
| Start date | 3 October 2024 |
| Primary completion | 3 January 2025 |
| Estimated completion | 3 March 2025 |
Drugs / interventions tested
- Resistance exercise intervention
- Routine care
Conditions studied
- Hemodialysis — all drugs for Hemodialysis →
Sponsor
Teng Zeng
Who can join
60 and older, any sex, with Hemodialysis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn if an intradialytic resistance exercise intervention works to reduce the symptom burden in older maintenance hemodialysis patients. It will also learn about safety of the intradialytic resistance exercise intervention program. The main questions it aims to answer are: 1. Does intradialytic resistance exercise effectively improve the number, frequency, and severity of symptoms in older patients? 2. What adverse events may occur among older dialysis patients during exercise? Researchers will compare older dialysis patients who undergo the intradialytic resistance exercise intervention with those receiving standard care to observe whether resistance exercise can improve symptom burden. Participants will: 1. Take an intradialytic resistance exercise intervention program developed through joint decision-making by rehabilitation experts, dialysis center physicians, nurses, and patients, conducted three times a week for 20 minutes each session, over a duration of three months. 2. Visit the hospital a monthly for texts and examinations. 3. Keep a diary of the types and frequency of adverse events during and after the exercise sessions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06604221
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Resistance exercise intervention
Trials testing the same drug.
- NCT06324422 — Exercise as Treatment of Fatigue in Parkinson´s Disease · NA · recruiting
- NCT06172725 — Improvements by a Protein-rich Plant-based Diet and Resistance Exercise Program for Active Ageing · NA · completed
Other recruiting trials for Hemodialysis
Currently open trials in the same condition.
- NCT07278973 — Hemodiafiltration Versus Hemodialysis in Older People · NA · recruiting
- NCT07438925 — Copeptin Concentration Measured in Plasma Samples and Intradialytic Blood Pressure Variation · active not recruiting
- NCT07234890 — Study to Evaluate the Effects of AV-001 on HD-induced Brain Injury. · Phase 2 · recruiting
- NCT07512895 — The Effect of Progressive Muscle Relaxation Exercises on Depression and Fatigue in Patients Receiving Hemodialysis Treat · NA · recruiting
- NCT07076888 — Aerobic Exercises and Hemodialysis Patients · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06604221 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Teng Zeng
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06604221.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing